<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35302283</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Influenza and other respiratory viruses</Title><ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation></Journal><ArticleTitle>Viral co-infections are associated with increased rates of hospitalization in those with influenza.</ArticleTitle><Pagination><StartPage>780</StartPage><EndPage>788</EndPage><MedlinePgn>780-788</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.12967</ELocationID><Abstract><AbstractText Label="BACKGROUND">Influenza causes significant morbidity and mortality in the United States. Among patients infected with influenza, the presence of bacterial co-infection is associated with worse clinical outcomes; less is known regarding the clinical importance of viral co-infections. The objective of this study was to determine rates of viral co-infections in emergency department (ED) patients with confirmed influenza and association of co-infection with disease severity.</AbstractText><AbstractText Label="METHODS">Secondary analysis of a biorepository and clinical database from a parent study where rapid influenza testing was implemented in four U.S. academic EDs, during the 2014-2015 influenza season. Patients were systematically tested for influenza virus using a validated clinical decision guideline. Demographic and clinical data were extracted from medical records; nasopharyngeal specimens from influenza-positive patients were tested for viral co-infections (ePlex, Genmark Diagnostics). Patterns of viral co-infections were evaluated using chi-square analysis. The association of viral co-infection with hospital admission was assessed using univariate and multivariate regression.</AbstractText><AbstractText Label="RESULTS">The overall influenza A/B positivity rate was 18.1% (1071/5919). Of the 999 samples with ePlex results, the prevalence of viral co-infections was 7.9% (79/999). The most common viral co-infection was rhinovirus/enterovirus (RhV/EV), at 3.9% (39/999). The odds of hospital admission (OR 2.33, 95% CI: 1.01-5.34) increased significantly for those with viral co-infections (other than RhV/EV) versus those with influenza A infection only.</AbstractText><AbstractText Label="CONCLUSION">Presence of viral co-infection (other than RhV/EV) in ED influenza A/B positive patients was independently associated with increased risk of hospital admission. Further research is needed to determine clinical utility of ED multiplex testing.</AbstractText><CopyrightInformation>© 2022 The Authors. Influenza and Other Respiratory Viruses published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shannon</LastName><ForeName>Kerry L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osula</LastName><ForeName>Valerie O</ForeName><Initials>VO</Initials><Identifier Source="ORCID">0000-0001-8226-2749</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw-Saliba</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardick</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McBryde</LastName><ForeName>Breana</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dugas</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Yu-Hsiang</ForeName><Initials>YH</Initials><Identifier Source="ORCID">0000-0002-1616-8014</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansoti</LastName><ForeName>Bhakti</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of International Health, Johns Hopkins University School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothman</LastName><ForeName>Richard E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Emergency Department National Influenza Network Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HHSN272201400007C</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Influenza Other Respir Viruses</MedlineTA><NlmUniqueID>101304007</NlmUniqueID><ISSNLinking>1750-2640</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009975" MajorTopicYN="Y">Orthomyxoviridae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">co-infection</Keyword><Keyword MajorTopicYN="N">emergency department</Keyword><Keyword MajorTopicYN="N">hospitalization</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">multiplex</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Steele</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stubbs</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kemble</LastName><ForeName>Laurie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beckham</LastName><ForeName>Danielle</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neal</LastName><ForeName>Niccole</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lovecchio</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mulrow</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Talan</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moran</LastName><ForeName>Greg</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krishnadasan</LastName><ForeName>Anusha</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pathmarajah</LastName><ForeName>Kavitha</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torrez</LastName><ForeName>Raquel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>Gabina</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quinteros Urzagaste</LastName><ForeName>Noemi</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Furoy</LastName><ForeName>Jacklyn</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Mayra</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Collison</LastName><ForeName>Claire</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dugas</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duval</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beard</LastName><ForeName>Raphaelle</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Avornu</LastName><ForeName>Ama</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Medina</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>18</Day><Hour>8</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35302283</ArticleId><ArticleId IdType="pmc">PMC9178061</ArticleId><ArticleId IdType="doi">10.1111/irv.12967</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Influenza (Seasonal). World Health Organization
. Accessed June 28, 2021, https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal
</Citation></Reference><Reference><Citation>Keilman LJ. Seasonal influenza (flu). Nurs Clin North Am Jun 2019;54(2):227–243. doi:10.1016/j.cnur.2019.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnur.2019.02.009</ArticleId><ArticleId IdType="pubmed">31027663</ArticleId></ArticleIdList></Reference><Reference><Citation>
Disease Burden of Influenza. Centers for Disease Control and Prevention
. Accessed June 28, 2021, https://www.cdc.gov/flu/about/burden/index.html
</Citation></Reference><Reference><Citation>Martin‐Loeches I, Schultz, MJ , Vincent JL, et al. Increased incidence of co‐infection in critically ill patients with influenza. Intensive Care Med 2017;43(1):48–58. doi:10.1007/s00134-016-4578-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4578-y</ArticleId><ArticleId IdType="pubmed">27709265</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein EY, Monteforte B, Gupta A, et al. The frequency of influenza and bacterial coinfection: a systematic review and meta‐analysis. Influenza Other Respir Viruses Sep 2016;10(5):394–403. doi:10.1111/irv.12398</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12398</ArticleId><ArticleId IdType="pmc">PMC4947938</ArticleId><ArticleId IdType="pubmed">27232677</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalil AC, Thomas PG. Influenza virus‐related critical illness: pathophysiology and epidemiology. Crit Care. Jul 19, 2019;23(1):258. doi:10.1186/s13054-019-2539-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2539-x</ArticleId><ArticleId IdType="pmc">PMC6642581</ArticleId><ArticleId IdType="pubmed">31324202</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice TW, Rubinson L, Uyeki TM, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med May 2012;40(5):1487–1498. doi:10.1097/CCM.0b013e3182416f23</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3182416f23</ArticleId><ArticleId IdType="pmc">PMC3653183</ArticleId><ArticleId IdType="pubmed">22511131</ArticleId></ArticleIdList></Reference><Reference><Citation>Goka E, Vallely P, Mutton K, Klapper P. Influenza A viruses dual and multiple infections with other respiratory viruses and risk of hospitalisation and mortality. Influenza Other Respir Viruses Nov 2013;7(6):1079–1087. doi:10.1111/irv.12020</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12020</ArticleId><ArticleId IdType="pmc">PMC4634299</ArticleId><ArticleId IdType="pubmed">23078095</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah NS, Greenberg JA, McNulty MC, et al. Bacterial and viral co‐infections complicating severe influenza: incidence and impact among 507 U.S. patients, 2013‐14. J Clin Virol. 2016;80:12‐19. doi:10.1016/j.jcv.2016.04.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2016.04.008</ArticleId><ArticleId IdType="pmc">PMC7185824</ArticleId><ArticleId IdType="pubmed">27130980</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardick J, Shaw‐Saliba K, McBryde B, et al. Identification of pathogens from the upper respiratory tract of adult emergency department patients at high risk for influenza complications in a pre‐Sars‐CoV‐2 environment. Diagn Microbiol Infect Dis Jun 2021;100(2):115352. doi:10.1016/j.diagmicrobio.2021.115352</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2021.115352</ArticleId><ArticleId IdType="pmc">PMC8107121</ArticleId><ArticleId IdType="pubmed">33639376</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S, Self WH, Wunderink RG, et al. Community‐acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med Jul 30, 2015;373(5):415–427. doi:10.1056/NEJMoa1500245</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1500245</ArticleId><ArticleId IdType="pmc">PMC4728150</ArticleId><ArticleId IdType="pubmed">26172429</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugas A, Rothman R. Clinical utility of rapid molecular‐based influenza testing. Open Forum Infect Dis. 2015;2(Suppl 1):102. doi:10.1093/ofid/ofv131.22</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofv131.22</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugas AF, Hsieh YH, LoVecchio F, et al. Derivation and validation of a clinical decision guideline for influenza testing in 4 US emergency departments. Clin Infect Dis Jan 1, 2020;70(1):49–58. doi:10.1093/cid/ciz171</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciz171</ArticleId><ArticleId IdType="pubmed">30843056</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez AJ, Ijezie EC, Balemba OB, Miura TA. Attenuation of Influenza A Virus Disease Severity by Viral Coinfection in a Mouse Model. J Virol. Dec 1, 2018;92(23). doi:10.1128/jvi.00881-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00881-18</ArticleId><ArticleId IdType="pmc">PMC6232468</ArticleId><ArticleId IdType="pubmed">30232180</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu A, Mihaylova VT, Landry ML, Foxman EF. Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study. Lancet Microbe Oct 2020;1(6):e254‐e262. doi:10.1016/s2666-5247(20)30114-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2666-5247(20)30114-2</ArticleId><ArticleId IdType="pmc">PMC7580833</ArticleId><ArticleId IdType="pubmed">33103132</ArticleId></ArticleIdList></Reference><Reference><Citation>Drews AL, Atmar RL, Glezen WP, Baxter BD, Piedra PA, Greenberg SB. Dual respiratory virus infections. Clin Infect Dis Dec 1997;25(6):1421–1429. doi:10.1086/516137</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/516137</ArticleId><ArticleId IdType="pmc">PMC7110088</ArticleId><ArticleId IdType="pubmed">9431390</ArticleId></ArticleIdList></Reference><Reference><Citation>Green DA, Hitoaliaj L, Kotansky B, Campbell SM, Peaper DR. Clinical utility of on‐demand multiplex respiratory pathogen testing among adult outpatients. J Clin Microbiol Dec 2016;54(12):2950–2955. doi:10.1128/jcm.01579-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.01579-16</ArticleId><ArticleId IdType="pmc">PMC5121384</ArticleId><ArticleId IdType="pubmed">27654334</ArticleId></ArticleIdList></Reference><Reference><Citation>Semret M, Schiller I, Jardin BA, et al. Multiplex respiratory virus testing for antimicrobial stewardship: a prospective assessment of antimicrobial use and clinical outcomes among hospitalized adults. J Infect Dis. Nov 15, 2017;216(8):936–944. doi:10.1093/infdis/jix288</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix288</ArticleId><ArticleId IdType="pmc">PMC5853820</ArticleId><ArticleId IdType="pubmed">29149338</ArticleId></ArticleIdList></Reference><Reference><Citation>May L, Tatro G, Poltavskiy E, et al. Rapid multiplex testing for upper respiratory pathogens in the emergency department: a randomized controlled trial. Open Forum Infect Dis. Dec 2019;6(12):ofz481. doi:10.1093/ofid/ofz481</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofz481</ArticleId><ArticleId IdType="pmc">PMC7043218</ArticleId><ArticleId IdType="pubmed">32128326</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S, Lamb MM, Moss A, et al. Effect of rapid respiratory virus testing on antibiotic prescribing among children presenting to the emergency department with acute respiratory illness: a randomized clinical trial. JAMA Netw Open. Jun 1, 2021;4(6):e2111836. doi:10.1001/jamanetworkopen.2021.11836</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11836</ArticleId><ArticleId IdType="pmc">PMC8178728</ArticleId><ArticleId IdType="pubmed">34086034</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen GT, Moore J, Herding E, et al. Clinical decision making in the emergency department setting using rapid PCR: results of the CLADE study group. J Clin Virol May 2018;102:42–49. doi:10.1016/j.jcv.2018.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.02.013</ArticleId><ArticleId IdType="pmc">PMC7106512</ArticleId><ArticleId IdType="pubmed">29494950</ArticleId></ArticleIdList></Reference><Reference><Citation>Egilmezer E, Walker GJ, Bakthavathsalam P, et al. Systematic review of the impact of point‐of‐care testing for influenza on the outcomes of patients with acute respiratory tract infection. Rev Med Virol Sep 2018;28(5):e1995. doi:10.1002/rmv.1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1995</ArticleId><ArticleId IdType="pmc">PMC7169080</ArticleId><ArticleId IdType="pubmed">30101552</ArticleId></ArticleIdList></Reference><Reference><Citation>Loevinsohn G, Hardick J, Sinywimaanzi P, et al. Respiratory pathogen diversity and co‐infections in rural Zambia. Int J Infect Dis Jan 2021;102:291–298. doi:10.1016/j.ijid.2020.10.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.054</ArticleId><ArticleId IdType="pmc">PMC7817328</ArticleId><ArticleId IdType="pubmed">33127501</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Li H, Tang Y, et al. Multiplex tests for respiratory tract infections: the direct utility of the filmarray respiratory panel in emergency department. Can Respir J. 2020;2020:6014563. doi:10.1155/2020/6014563</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6014563</ArticleId><ArticleId IdType="pmc">PMC7397412</ArticleId><ArticleId IdType="pubmed">32774562</ArticleId></ArticleIdList></Reference><Reference><Citation>King JC, Beigel JH, Ison MG, et al. Clinical development of therapeutic agents for hospitalized patients with influenza: challenges and innovations. Open Forum Infect Dis Apr 2019;6(4):ofz137. doi:10.1093/ofid/ofz137</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofz137</ArticleId><ArticleId IdType="pmc">PMC6479095</ArticleId><ArticleId IdType="pubmed">31037242</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>